Erasmus School of Health Policy & Management
External PhD candidate | Health Technology Assessment (HTA)
- chen@eshpm.eur.nl
More information
Work
- Yi Hsuan Chen, Michiel Kroesen, Mischa Hoogeman, Matthijs Versteegh, Carin Uyl-de Groot & Hedwig M. Blommestein (2025) - Treatment-related toxicity, utility and patient-reported outcomes of head and neck cancer patients treated with proton therapy: A longitudinal study - Clinical and Translational Radiation Oncology, 51 - doi: 10.1016/j.ctro.2025.100913 - [link]
- Michelle Oud, Sebastiaan Breedveld, Marta Giżyńska, Yi Hsuan Chen, Steven Habraken, Zoltán Perkó, Ben Heijmen & Mischa Hoogeman (2024) - Dosimetric advantages of adaptive IMPT vs. Enhanced workload and treatment time – A need for automation - Radiotherapy and Oncology, 201 - doi: 10.1016/j.radonc.2024.110548 - [link]
- Yi Hsuan Chen, Hedwig M. Blommestein, Reinder Klazenga, Carin Uyl-de Groot & Marco van Vulpen (2023) - Costs of Newly Funded Proton Therapy Using Time-Driven Activity-Based Costing in The Netherlands - Cancers, 15 (2) - doi: 10.3390/cancers15020516 - [link]
- Yi Hsuan Chen, Dominique Molenaar, Carin A. Uyl-De Groot, Marco van Vulpen & Hedwig M. Blommestein (2022) - Medical Resource Use and Medical Costs for Radiotherapy-Related Adverse Effects: A Systematic Review - Cancers, 14 (10) - doi: 10.3390/cancers14102444 - [link]
- Yi Hsuan Chen, MPMH (Maureen) Rutten - van Molken & M (Milad) Karimi (2020) - The disease burden of multimorbidity and its interaction with educational level - PLoS One (online), 12 (15) - doi: 10.1371/journal.pone.0243275 - [link]
